Salomon & Ludwin’s DexCom DXCM Stock Holding History

Salomon & Ludwin’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$16.7K	Sell	193 -108	-36%	-$8.99K	﹤0.01%	1052
2026 Q2	$20.7K	Buy	301 +32	+12%	+$2.13K	﹤0.01%	1123
2026 Q1	$16.7K	Sell	269 -9	-3%	-$627	﹤0.01%	1214
2025 Q4	$18.8K	Buy	278 +6	+2%	+$388	﹤0.01%	949
2025 Q3	$18.2K	Buy	272 +68	+33%	+$5.38K	﹤0.01%	873
2025 Q2	$17K	Buy	204 +160	+364%	+$12.5K	﹤0.01%	412
2025 Q1	$3K	Hold	44	–	–	﹤0.01%	556
2024 Q4	$3.42K	Hold	44	–	–	﹤0.01%	540
2024 Q3	$2.95K	Buy	+44	New	+$3.61K	﹤0.01%	573
2020 Q2	–	Sell	-520	Closed	-$35K	–	112
2020 Q1	$35K	Buy	+520	New	+$32.4K	0.01%	108

Other funds holding DXCM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Salomon & Ludwin's DXCM Position: Q3 2026 in Review

Salomon & Ludwin reduced its DexCom (DXCM) stake by 36% in Q3 2026, selling an estimated $8.99K and leaving 193 shares worth $16.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1052.

Salomon & Ludwin first reported a position in DXCM in Q1 2020 and has held it in 10 quarters since. The position peaked at $35K in Q1 2020. 516 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

Salomon & Ludwin held 193 shares of DexCom worth $16.7K as of Q3 2026.
Salomon & Ludwin sold 108 DexCom shares in Q3 2026, an estimated $8.99K.
DexCom made up ﹤0.01% of Salomon & Ludwin's portfolio in Q3 2026, its #1052 holding.
Salomon & Ludwin first reported a position in DexCom in Q1 2020 and has held it in 10 quarters since.
Salomon & Ludwin's DexCom position peaked at $35K in Q1 2020.
516 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Salomon & Ludwin's 13F filing for Q3 2026, filed 29 Oct 2026.